Free Trial

Alkemy Capital Investments (ALK) Competitors

Alkemy Capital Investments logo
GBX 127.35 -2.65 (-2.04%)
(As of 12/20/2024 11:09 AM ET)

ALK vs. PXS, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, AAL, and CCL

Should you be buying Alkemy Capital Investments stock or one of its competitors? The main competitors of Alkemy Capital Investments include Provexis (PXS), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), and Carnival Co. & (CCL). These companies are all part of the "transportation" industry.

Alkemy Capital Investments vs.

Provexis (LON:PXS) and Alkemy Capital Investments (LON:ALK) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Provexis has higher revenue and earnings than Alkemy Capital Investments.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Provexis£426.17K34.47N/AN/AN/A
Alkemy Capital InvestmentsN/AN/A-£1.77M-£0.23-553.70

In the previous week, Alkemy Capital Investments had 1 more articles in the media than Provexis. MarketBeat recorded 1 mentions for Alkemy Capital Investments and 0 mentions for Provexis. Provexis' average media sentiment score of 0.00 equaled Alkemy Capital Investments'average media sentiment score.

Company Overall Sentiment
Provexis Neutral
Alkemy Capital Investments Neutral

7.9% of Provexis shares are owned by institutional investors. Comparatively, 1.5% of Alkemy Capital Investments shares are owned by institutional investors. 21.6% of Provexis shares are owned by insiders. Comparatively, 43.7% of Alkemy Capital Investments shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alkemy Capital Investments received 92 more outperform votes than Provexis when rated by MarketBeat users. Likewise, 76.88% of users gave Alkemy Capital Investments an outperform vote while only 64.21% of users gave Provexis an outperform vote.

CompanyUnderperformOutperform
ProvexisOutperform Votes
61
64.21%
Underperform Votes
34
35.79%
Alkemy Capital InvestmentsOutperform Votes
153
76.88%
Underperform Votes
46
23.12%

Alkemy Capital Investments has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Alkemy Capital Investments' return on equity of 0.00% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Provexis-73.10% -138.67% -56.14%
Alkemy Capital Investments N/A N/A -258.00%

Provexis has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Alkemy Capital Investments has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500.

Summary

Alkemy Capital Investments beats Provexis on 7 of the 11 factors compared between the two stocks.

Get Alkemy Capital Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALK vs. The Competition

MetricAlkemy Capital InvestmentsShell Companies IndustryFinancial SectorLON Exchange
Market Cap£11.22M£56.56M£3.69B£1.86B
Dividend YieldN/A4.97%4.42%6.19%
P/E Ratio-553.7035.27419.531,797.43
Price / SalesN/A620.302,223.64380,062.11
Price / Cash1,550.00164.8552.1628.19
Price / Book-21.234.071.472.92
Net Income-£1.77M-£2.13M£358.52M£156.26M
7 Day Performance-7.38%-0.17%-1.62%-1.92%
1 Month Performance22.45%2.43%0.70%17.74%
1 Year Performance21.29%-0.30%9.93%29.21%

Alkemy Capital Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALK
Alkemy Capital Investments
N/AGBX 127.35
-2.0%
N/A+26.7%£11.22MN/A-553.7025,500Gap Up
PXS
Provexis
N/AGBX 0.63
-7.4%
N/A+8.3%£14.18M£426,168.0043.754Gap Down
SHIP
Tufton Oceanic Assets
N/AGBX 1.20
flat
N/A+23.8%£3.51M£39.75M9.9950
TORO
Chenavari Toro Income Fund
N/AGBX 0.57
+2.5%
N/A+26.4%£1.75MN/A-18.97N/AGap Up
CLCO
CloudCoCo Group
N/AGBX 0.23
-18.2%
N/A-71.4%£1.59M£27.31M-115.00125Gap Down
High Trading Volume
ICON
Iconic Labs
N/AGBX 5.25
+144.2%
N/A+27.3%£586,000.00£600,855.00-15.003Gap Up
High Trading Volume
PAA
22532 (PAA.L)
N/AN/AN/AN/A£0.00N/A0.004,100Gap Up
High Trading Volume
GEL
Greka Engineering & Technology
N/AN/AN/AN/A£0.00N/A0.002,110
MMP
Marwyn Management Partners
N/AN/AN/AN/A£0.00N/A0.001,660
AAL
Anglo American
1.1874 of 5 stars
GBX 2,436.50
-1.0%
GBX 2,715
+11.4%
+21.7%£29.48B£29.44B-2,341.83129,700Insider Trade
News Coverage
CCL
Carnival Co. &
N/AGBX 1,859.50
-0.6%
N/A+41.8%£2.69B£24.48B2,101.1240,000News Coverage
Gap Down

Related Companies and Tools


This page (LON:ALK) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners